These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10579544)

  • 1. Serotonergic dysfunction in women with pure premenstrual dysphoric disorder: is the fenfluramine challenge test still relevant?
    Steiner M; Yatham LN; Coote M; Wilkins A; Lepage P
    Psychiatry Res; 1999 Oct; 87(2-3):107-15. PubMed ID: 10579544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests.
    Inoue Y; Terao T; Iwata N; Okamoto K; Kojima H; Okamoto T; Yoshimura R; Nakamura J
    Psychopharmacology (Berl); 2007 Feb; 190(2):213-9. PubMed ID: 17072588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder.
    FitzGerald M; Malone KM; Li S; Harrison WM; McBride PA; Endicott J; Cooper T; Mann JJ
    Am J Psychiatry; 1997 Apr; 154(4):556-8. PubMed ID: 9090347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum brain-derived neurotrophic factor differences between the luteal and follicular phases in premenstrual dysphoric disorder.
    Oral E; Kirkan TS; Yildirim A; Kotan Z; Cansever Z; Ozcan H; Aliyev E; Gulec M
    Gen Hosp Psychiatry; 2015; 37(3):266-72. PubMed ID: 25799087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. d-fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen-induced alteration.
    O'Keane V; O'Hanlon M; Webb M; Dinan T
    Clin Endocrinol (Oxf); 1991 Apr; 34(4):289-92. PubMed ID: 1879060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menstrual cycle effects on amygdala reactivity to emotional stimulation in premenstrual dysphoric disorder.
    Gingnell M; Morell A; Bannbers E; Wikström J; Sundström Poromaa I
    Horm Behav; 2012 Sep; 62(4):400-6. PubMed ID: 22814368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle.
    Kask K; Gulinello M; Bäckström T; Geyer MA; Sundström-Poromaa I
    Neuropsychopharmacology; 2008 Aug; 33(9):2283-90. PubMed ID: 17940552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT brain function in affective disorder: d,l-fenfluramine-induced hormone release and clinical outcome in long-term lithium/carbamazepine prophylaxis.
    Mannel M; Müller-Oerlinghausen B; Czernik A; Sauer H
    J Affect Disord; 1997 Nov; 46(2):101-13. PubMed ID: 9479614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
    Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH
    Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria.
    Jovanovic H; Cerin A; Karlsson P; Lundberg J; Halldin C; Nordström AL
    Psychiatry Res; 2006 Dec; 148(2-3):185-93. PubMed ID: 17085022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurohormonal responses to D-fenfluramine in healthy elderly subjects. A placebo-controlled study.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Psychoneuroendocrinology; 2000 Feb; 25(2):139-50. PubMed ID: 10674278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cognitive emotion regulation strategies on mood and cortisol in daily life in women with premenstrual dysphoric disorder.
    Nayman S; Beddig T; Reinhard I; Kuehner C
    Psychol Med; 2023 Aug; 53(11):5342-5352. PubMed ID: 35979813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of premenstrual dysphoric disorder and menstrual cycle phase on brain activity during response inhibition.
    Bannbers E; Gingnell M; Engman J; Morell A; Comasco E; Kask K; Garavan H; Wikström J; Sundström Poromaa I
    J Affect Disord; 2012 Dec; 142(1-3):347-50. PubMed ID: 22840469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic function and suicidal behavior in schizophrenia.
    Corrêa H; Duval F; Mokrani MC; Bailey P; Trémeau F; Staner L; Diep TS; Crocq MA; Macher JP
    Schizophr Res; 2002 Jul; 56(1-2):75-85. PubMed ID: 12084422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The late-luteal leptin level, caloric intake and eating behaviors among women with premenstrual dysphoric disorder.
    Ko CH; Yen CF; Long CY; Kuo YT; Chen CS; Yen JY
    Psychoneuroendocrinology; 2015 Jun; 56():52-61. PubMed ID: 25800149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder.
    Girdler SS; Straneva PA; Light KC; Pedersen CA; Morrow AL
    Biol Psychiatry; 2001 May; 49(9):788-97. PubMed ID: 11331087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
    Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive mood and frontal alpha asymmetry during the luteal phase in premenstrual dysphoric disorder.
    Lin IM; Tsai YC; Peper E; Yen CF
    J Obstet Gynaecol Res; 2013 May; 39(5):998-1006. PubMed ID: 23551544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premenstrual appetite and emotional responses to foods among women with premenstrual dysphoric disorder.
    Yen JY; Liu TL; Chen IJ; Chen SY; Ko CH
    Appetite; 2018 Jun; 125():18-23. PubMed ID: 29407746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.
    Timby E; Bäckström T; Nyberg S; Stenlund H; Wihlbäck AN; Bixo M
    Psychopharmacology (Berl); 2016 Jun; 233(11):2109-2117. PubMed ID: 26960697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.